HRONIC MYELOGENOUS LEUKEMIA (CML) is a C clonal disorder originating from a plunpotent hematopoietic stem cell common to granulocytes, monocytes/macrophages, erythrocytes, megakaryocytes, and Blymphocytes.'.' Whether T-cells are involved in CML is still contr~versial.~ In the chronic phase of CML, evidence against T-cell involvement includes absence of the Philadelphia chromosome (Ph'),4 of clonal breakpoint cluster region (BCR) rearrangement' and heterozygous expression of glucose-6-phosphatase dehydrogenase (G6PD) in T-celk2 However, cumulative evidence seems to favor the involvement of T-cell in the acute phase of CML.'.6-'6 Most reports demonstrated T-lymphoblasts in the peripheral blood and/or bone marrow in CML patients.'."l6 Some cases demonstrated extramedullary T-cell blast crisis in lymph node^'^-'^ and one case, in a subcutaneous tumor.27 We report here a unique case of CML with penetrance of the Ph' molecular alteration into the T-cell lineage of a paraspinal tumor.From the *Departments of Laboratories and ?Medicine, North Shore University Hospital-Cornell University Medical College, Manhasset. New York.The authors thank Eleonore Boss and Lisa Moskowitz for technical assistance and Lynn Bartholomew for secretarial assistance.Address for reprints: Tsieh Sun, MD, Department of Laboratories, North Shore University Hospital-Cornell University Medical College. Manhasset. NY 11030.Accepted for publication January 2, 1991.
Case ReportThe patient was first seen in July 1984 at the age of 63 years when she was admitted to the hospital with left upper quadrant pain, fatigue, and an elevated leukocyte count. Hepatosplenomegaly was noticed on physical examination. Laboratory data showed a hemoglobin of 10.8 g/dl, hematocrit 35.8570, and leukocyte count 178 X 109/1 with the differential typical of chronic myelogenous leukemia. A nuclear liver/spleen scan revealed splenomegaly and a probable splenic infarct. A bone marrow aspirate was characteristic of CML. Cytogenetic studies were not done. The patient had a good clinical response to oral Myleran (busulphan) and allopurinol and within 3 months of therapy, both her leukocyte count and size of her spleen dramatically declined. Her counts remained relatively stable on low doses of Myleran, her only side effect being mild hyperpigmentation. The patient required the institution of beta blockers and diuretics for hypertension as well as of Synthroid (sodium levothyroxine) for hypothyroidism that developed during this interval.In May 1989, the patient had back pain for which she took nonsteroidal antiinflammatory drugs. Shortly thereafter, she had guaiac-positive stools and on gastroscopy, two benign-appearing gastric ulcers were documented. When her back pain intensified, local radiographs showed scoliosis, degenerative disc disease with severe disc narrowing at lumbar vertebrae 4 and 5. A bone scan in June 1989 showed collapse of thoracic vertebra 11 and magnetic resonance imaging (MRI) of spine showed evidence of lytic lesion with a soft tissue mass at T 1 1. Because...